B-Ingelheim ramping up China manufacturing to meet growing demand
This article was originally published in Scrip
Executive Summary
A €70 million investment in Boehringer Ingelheim's existing manufacturing facility in China is planned to support the growth of the private German group's business in the country, where it sees Shanghai becoming a key component of its global production network.